🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

TD Cowen sees Varonis stock climbing on SaaS traction and healthy new business

EditorEmilio Ghigini
Published 10/30/2024, 06:42 AM
VRNS
-

On Wednesday, Varonis Systems (NASDAQ:VRNS) stock maintained its Buy rating and a price target of $65.00, following a solid third-quarter performance. The company saw an 18% year-over-year growth in Annual Recurring Revenue (ARR), an upward revision in their guidance, and a faster-than-expected transition to Software as a Service (SaaS). Moreover, Varonis is experiencing positive momentum in its Managed Detection and Response (MDR) offerings.

The firm's third-quarter success was attributed to robust enterprise demand, especially from new business, with healthy conversion rates. Despite a slight slowdown in the federal vertical, the overall secular tailwinds for the company remain strong. The adoption of SaaS solutions by Varonis is surpassing initial timelines, indicating a swift strategic shift that is resonating positively with its customer base.

Varonis also noted the emerging contribution of General Artificial Intelligence (Gen AI) to its business results. Although in its early stages, Gen AI is starting to make a tangible impact. This technological advancement is expected to further bolster Varonis' market position as it continues to evolve and integrate into the company's offerings.

The reaffirmed Buy rating and price target reflect the company's confidence in Varonis' operational strategy and market opportunities. The analyst's commentary underscored the company's robust quarter, driven by significant growth factors and technological advancements that are expected to continue supporting Varonis' upward trajectory.

In other recent news, Varonis Systems has reported strong earnings, surpassing consensus estimates, with Net New Annual Recurring Revenue (NNARR) exceeding expectations by $5 million. The company's Annual Recurring Revenue (ARR) demonstrated consistent growth, contributing to an improved Fiscal Year 2025 ARR guidance, projecting growth of 17-18% year-over-year. DA Davidson, UBS, and Baird have all raised their price targets for Varonis Systems, reflecting this positive performance.

Varonis Systems has also announced plans to offer $350 million in Convertible Senior Notes due 2029, with an additional option for initial purchasers to buy up to $52.5 million more. In addition, the company introduced new data security features at Dreamforce 2024, aimed at enhancing data security for Salesforce (NYSE:CRM) customers.

Multiple firms, including FBN Securities, Truist Securities, and Citi, have raised their price targets for Varonis, citing its strong Q2 results and successful shift to a SaaS business model. These recent developments highlight Varonis Systems' ongoing momentum in the data security and analytics sector.

InvestingPro Insights

Varonis Systems' strong performance in Q3 2023 is reflected in several key metrics from InvestingPro. The company's revenue growth of 6.57% over the last twelve months and an impressive 12.93% in Q2 2024 align with the reported 18% year-over-year growth in Annual Recurring Revenue. This growth trajectory is further supported by Varonis' high gross profit margin of 84.54%, showcasing the company's efficiency in its core operations.

InvestingPro Tips highlight that Varonis holds more cash than debt on its balance sheet and has liquid assets exceeding short-term obligations. These factors contribute to the company's financial stability as it continues its transition to SaaS and invests in emerging technologies like Gen AI.

The market's positive reception of Varonis' strategic direction is evident in its stock performance. InvestingPro data shows a substantial 86.6% price return over the past year, with the stock trading at 97.03% of its 52-week high. This aligns with the analyst's maintained Buy rating and $65 price target.

For investors seeking a deeper understanding of Varonis' potential, InvestingPro offers 12 additional tips, providing a comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.